ReviewMarine drugs2018
Secondary Metabolites of Mangrove-Associated Strains of Talaromyces.
Review in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- Talaromyces marinus (Eurotiales, Trichocomaceae): a new marine fungus from the Red Sea, Egypt, with distinguished enzymatic capabilities.BMC microbiology · 2026Article
- Chemical Constituents of the Deep-Sea-Derived Fungus Talaromyces wortmannii and Their Ferroptosis Inhibitory Activity.Chemistry & biodiversity · 2026Article
- Exploring the efficacy of new potential bio-insecticides produced by Penicillium oxalicum against Culex pipiens larvae.BMC microbiology · 2026Article
- A Novel Bis-Spiroketal Scaffold and Other Secondary Metabolites from the Marine-Derived FungusMarine drugs · 2026Article
- Metabarcoding insights into the fungal diversity and biotechnological potential of mangrove sediments in Ecuador's Reserva Ecológica Manglares Churute.Frontiers in fungal biology · 2026Article
- Draft genome ofMicrobiology resource announcements · 2025Article
- Halophilic Fungi-Features and Potential Applications.Microorganisms · 2025Review
- Genomic Analysis ofGenes · 2024Article
- Three New Dipeptide and Two New Polyketide Derivatives from the Mangrove-Derived FungusMarine drugs · 2024Article
- Penicillides fromMolecules (Basel, Switzerland) · 2024Review
- Diversity of unique, nonmycorrhizal endophytic fungi in cultivatedPlant-environment interactions (Hoboken, N.J.) · 2024Article
- Bioactive polyketides and meroterpenoids from the mangrove-derived fungusFrontiers in microbiology · 2024Article
- Characterization and phylogenetic analysis of theMitochondrial DNA. Part B, Resources · 2024Article
- Extracts ofMicroorganisms · 2023Article
- The Outstanding Chemodiversity of Marine-DerivedBiomolecules · 2023Review
- Polyketides with potential bioactivities from the mangrove-derived fungusMarine life science & technology · 2023Article
- Study of marine microorganism metabolites: new resources for bioactive natural products.Frontiers in microbiology · 2023Review
- Unusual Secondary Metabolites from the Mangrove Ecosystems: Structures, Bioactivities, Chemical, and Bio-Syntheses.Marine drugs · 2022Review
- Review
- Talaromarins A-F: Six New Isocoumarins from Mangrove-Derived FungusMarine drugs · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Boosted by the general aim of exploiting the biotechnological potential of the microbial component of biodiversity, research on the secondary metabolite production of endophytic fungi has remarkably increased in the past few decades. Novel compounds and bioactivities have resulted from this work, which has stimulated a more thorough consideration of various natural ecosystems as conducive contexts for the discovery of new drugs. Thriving at the frontier between land and sea, mangrove forests represent one of the most valuable areas in this respect. The present paper offers a review of the research on the characterization and biological activities of secondary metabolites from manglicolous strains of species belonging to the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.